跳至主要内容
临床试验/NCT06813118
NCT06813118已完成1 期

A RCT Comparing the Effectiveness of a Combination Therapy of Lezra and Clomid Versus Lezra Alone for Inducing Ovulation in Women Diagnosed With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome

HITEC-Institute of Medical Sciences2 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2024年6月7日最近更新:
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
42
试验地点
2
主要终点
To compare the rate of ovulation

研究概览

简要总结

Clomiphene citrate resistant i.e failure to ovulate after 6 cycles of ovulation induction effects 15-40% of patients with PCOS.Two treatment groups will be formed one recieving letrozole alone and another recieving CC and letrozole combined.Mature follicles and endometrial thickness will be checked by transvaginal ultrasound and results will be recorded.

详细描述

Subfertility is characterized by the inability to achieve conception despite engaging in regular unprotected sexual intercourse for 1-2 years.PCOS exhibits chacteristic traits such as obesity,heightened insulin resistance accompanied by compensatory hyperinsulinemia,oligo/anovulation and subfertility.Clompiphene citrate induces ovarian stimulation.Letrozole ,an aromatase inhibitor emerges as a novel medication with comparable efficacy to CC as a first line treatment for inducing ovulation in cases of anovulation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

lottery method for selection

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • women of 20-40 years with a history of PCOS and resistant to CC

排除标准

  • Premature ovarian insufficiency
  • Husband has oligo azoospermia
  • Hypothyroidism
  • Hyperprolactinemia

研究组 & 干预措施

group 1

Experimental

clomiphene citrate and letrozole combination

干预措施: Clomiphene Citrate and letrozole (Drug)

group 2

Experimental

letrozole alone

干预措施: Clomiphene Citrate and letrozole (Drug)

结局指标

主要结局

To compare the rate of ovulation

时间窗: 6 months

To compare the rate of ovulation between letrozole alone and letrozole and CC

次要结局

未报告次要终点

研究者

发起方
HITEC-Institute of Medical Sciences
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rukhsana Shaheen Afzal

Assistant Professor

HITEC-Institute of Medical Sciences

研究点 (2)

Loading locations...

相似试验